Stem cell therapy for Parkinson's disease
Part of Brain & nervous system clinical trials.
This study tests a new stem cell treatment for Parkinson's disease. It aims to see if the treatment is safe and may help improve symptoms when current medications stop working well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had Parkinson's disease for at least 5 years.
- Your Parkinson's symptoms respond to levodopa medication.
- Your symptoms impact your daily life despite current treatment.
- You are not pregnant or planning to become pregnant (or father a child) during the trial.
- You have not had cancer or a stroke in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a special type of stem cell treatment can help people with Parkinson's disease or certain atypical parkinsonism conditions. The treatment involves harvesting your own bone marrow stem cells and optimizing them in the lab before giving them back to you. It aims to see if this can slow down the disease or improve symptoms.
This trial tests whether transplanting specially grown cells (DopaCell) into the brain can safely help people with moderate Parkinson's disease whose symptoms aren't well controlled by medication. The cells are intended to produce dopamine, the chemical that Parkinson's affects.
This trial tests a new treatment called NouvNeu001 for people with Parkinson's disease. It aims to see if it's safe, feasible, and effective in improving motor symptoms.
This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.
This trial uses special stem cells (made from skin or blood cells) to replace damaged brain cells in people with Parkinson's. The goal is to see if these cells can improve movement and reduce symptoms.
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
Hear when a new Neurodegenerative Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.